ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Cherokee Expanding Former Merck Plant

by Rick Mullin
November 24, 2008 | APPEARED IN VOLUME 86, ISSUE 47

Cherokee Pharmaceuticals broke ground last week on a $2 million expansion to its active pharmaceutical ingredients (API) plant in Riverside, Pa. Cherokee was acquired from Merck & Co. by PRWT Services earlier this year and has the distinction of being the only minority-owned API producer in the U.S. The new capacity will be housed in a three-story building. Construction is scheduled to be completed by late 2009, and the firm expects to hire 10 to 20 new employees.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment